首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   280篇
  免费   23篇
  国内免费   4篇
  307篇
  2024年   3篇
  2023年   1篇
  2022年   3篇
  2021年   1篇
  2020年   6篇
  2019年   6篇
  2018年   7篇
  2017年   3篇
  2016年   9篇
  2015年   10篇
  2014年   11篇
  2013年   13篇
  2012年   7篇
  2011年   5篇
  2010年   12篇
  2009年   18篇
  2008年   11篇
  2007年   9篇
  2006年   13篇
  2005年   15篇
  2004年   20篇
  2003年   8篇
  2002年   15篇
  2001年   8篇
  2000年   2篇
  1999年   5篇
  1998年   6篇
  1997年   1篇
  1996年   5篇
  1995年   7篇
  1994年   4篇
  1993年   11篇
  1992年   9篇
  1991年   4篇
  1990年   4篇
  1989年   8篇
  1988年   3篇
  1987年   3篇
  1986年   1篇
  1985年   1篇
  1984年   2篇
  1983年   2篇
  1982年   5篇
  1980年   2篇
  1978年   3篇
  1977年   1篇
  1976年   2篇
  1975年   1篇
  1973年   1篇
排序方式: 共有307条查询结果,搜索用时 15 毫秒
301.
《Cell reports》2020,30(8):2603-2613.e3
  1. Download : Download high-res image (118KB)
  2. Download : Download full-size image
  相似文献   
302.
Cyclopenin m-hydroxylase transforms cyclopenin, one of the two major alkaloids of Penicillium cyclopium, into cyclopenol. The enzyme belongs to the group of mixed function oxygenases. It needs molecular oxygen and a hydrogen donor (NAD(P)H, ascorbic acid, tetrahydropteridine) as cosubstrates, and it is inhibited by CN? and SCN? but not by CO. Inhibition by dicoumarol indicates that it may be a flavoprotein. With the exception of the alkaloid viridicatin, all tested compounds structurally related to cyclopenin are hydroxylated. The hydroxylase activity is measurable in the cultures at the end of the growth phase, i.e. during the period of alkaloid metabolism.  相似文献   
303.
The enantiomers of the antiinflammatory drug Etodolac were separated without derivatization on Chiralcel OD and Pirkle (R)-DNBPG columns. Enantiomeric purity can be determined in less than 10 min. Optimization of separation was evaluated using various concentrations of 2-propanol (doped with TFA) in hexane as the mobile phase. © 1993 Wiley-Liss, Inc.  相似文献   
304.
305.
Mouse hepatocytes from healthy control mice and from Ehrlich ascites tumour-bearing mice were used for tracer-kinetic studies of purine catabolism of liver cells during different periods of tumour growth. The dynamics of the radioactive tracers were modelled mathematically by a system of differential equations. Computer simulations, i.e. direct fitting of numerical solutions of these equations to the observed time-courses of metabolites and specific radioactivites, enables one to estimate unknown kinetic parameters of a simplified model of pathways of hepatic purine catabolism in tumour-bearing mice. There occurred great differences of metabolic flux rates between control hepatocytes, hepatocytes of mice during the proliferating period of tumour growth (6th day after inoculation of the tumour) and hepatocytes of mice during the resting period of tumour growth (12th day after inoculation of the tumour). The final purine degradation of hepatocytes prepared during the proliferating period was lower in comparison with that of control hepatocytes, but it was markedly higher in hepatocytes prepared during the resting period of tumour growth. The changes in hepatocyte purine catabolism during the proliferating period of tumour growth argue for transitions which aim at the maintenance of high purine nucleotide levels in the liver itself rather than for an increased nucleoside and nucleobase supply for the tumour. This suggestion is in accordance with the increased ATP level of the liver during the proliferating phase of tumour growth. The drastic acceleration of the final steps of hepatic purine catabolism forming uric acid and allantoin during the resting period of tumour growth was predominantly due to increased flux rate from xanthosine and guanine in accordance with increased catabolism of monophosphorylated nucleotides.  相似文献   
306.
The available data concerning the ability of ceramide and other simple sphingolipids to segregate laterally into rigid, gel-like domains in a fluid bilayer has been reviewed. Ceramides give rise to rigid ceramide-enriched domains when their N-acyl chain is longer than C12. The high melting temperature of hydrated ceramides, revealing a tight intermolecular interaction, is probably responsible for their lateral segregation. Ceramides compete with cholesterol for the formation of domains with lipids such as sphingomyelin or saturated phosphatidylcholines; under these conditions displacement of cholesterol by ceramide involves a transition from a liquid-ordered to a gel-like phase in the domains involved. When ceramide is generated in situ by a sphingomyelinase, instead of being premixed with the other lipids, gel-like domain formation occurs as well, although the topology of the domains may not be the same, the enzyme causing clustering of domains that is not detected with premixed ceramide. Ceramide-1-phosphate is not likely to form domains in fluid bilayers, and the same is true of sphingosine and of sphingosine-1-phosphate. However, sphingosine does rigidify pre-existing gel domains in mixed bilayers.  相似文献   
307.
A retention model for the chiral separation of an uncharged solute, felodipine, on CHIRAL-AGP, using a micellar mobile phase is proposed. The model assumes the presence of two stereoselective sites and each enantiomer was found to interact with different sites. Addition of a chiral aliphatic alcohol, (+)-(S)-2-octanol, preferentially interacted with the binding site for (?)-(S)-felodipine. The monomeric form of the micellar agent (Tween® 20) competed with the enantiomers for the adsorption sites, and the formation of a 1:1 complex between the enantiomers and the micelles was assumed. The retention of the solutes was effectively controlled by adding small quantities (<1.63 × 10?3 M) of the nonionic detergent Tween 20 to the mobile phase. Baseline separation was achieved by addition of 1.0 mM n-octylamine to the mobile phase; 8.14 × 10?4 M Tween 20 in phosphate buffer pH 7.0. The separation factor (α = 1.74) was unaffected by the detergent concentration in the presence of 1.0 mM n-octylamine. © 1995 Wiley-Liss, Inc.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号